Protalix Ltd.

14 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Nov 2030

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Jan 30, 2027
The maintenance fee for Large scale disposable bioreactor (US 10,364,413) comes due Jan 30, 2027. Unpaid by Jul 30, 2027, it lapses early.
2 fees due May 14 to 24, 2027 · next May 14

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 9,708,595	Stabilized alpha-galactosidase and uses thereof In force Ends no later than Nov 17, 2030 · From the USPTO record	In force	Ends no later than Nov 17, 2030	From the USPTO record
US 10,280,414	Stabilized Alpha-Galactosidase and Uses Thereof In force Term ends Nov 17, 2030 · Medium confidence	In force	Term ends Nov 17, 2030	Medium confidence
US 10,870,842	Stabilized alpha-galactosidase and uses thereof In force Ends no later than Nov 17, 2030 · From the USPTO record	In force	Ends no later than Nov 17, 2030	From the USPTO record
US 12,385,026	Stabilized alpha-galactosidase and uses thereof In force Term ends Nov 17, 2030 · From the USPTO record	In force	Term ends Nov 17, 2030	From the USPTO record
US 10,364,413	Large scale disposable bioreactor In force Term ends Jan 29, 2032 · From the USPTO record	In force	Term ends Jan 29, 2032	From the USPTO record
US 9,603,906	Inhalable Liquid Formulations of Dnase I In force Ends no later than Jan 31, 2033 · Medium confidence	In force	Ends no later than Jan 31, 2033	Medium confidence
US 9,603,907	Dry Powder Formulations of Dnase I In force Ends no later than Jan 31, 2033 · Medium confidence	In force	Ends no later than Jan 31, 2033	Medium confidence
US 9,732,333	Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells In force Term ends Apr 21, 2033 · From the USPTO record	In force	Term ends Apr 21, 2033	From the USPTO record
US 9,194,011	Stabilized Alpha-Galactosidase and Uses Thereof In force Term ends Nov 17, 2035 · High confidence	In force	Term ends Nov 17, 2035	High confidence
US 11,814,657	Modified Dnase and Uses Thereof In force Ends no later than Jan 4, 2036 · Medium confidence	In force	Ends no later than Jan 4, 2036	Medium confidence

10 of 14 patents shown.

Pro members see all 14.

Pro members: see all 14 patents

Also on record, not counted in the 14: 8 lapsed for an unpaid fee · 6 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 6 abandoned · 13 no status recorded

List them